80% of those at high risk or who have had at least one osteoporotic fracture are not identified or treated. Widespread misinformation contributes to this, including articles on risks of radiation exposure from DXA scans and serious but rare adverse effects. In May 2016, the American Society for Bone and Mineral Research (ASBMR), National Osteoporosis Foundation (NOF), and National Bone Health Alliance (NBHA) sent an urgent call for doctors to be more aggressive treating patients at high risk of fractures, and for patients to be more aware of the need for treatment. Newer treatment options with potential for remarkable therapeutic outcomes may become available to help reach these goals.
NEW HORIZONS IN OSTEOPOROSIS: Building a Strong Foundation for Evidence-based Diagnosis and Treatment will clarify misperceptions and misinformation related to osteoporosis diagnosis and management. It will summarize strategies to identify patients who have sustained hip fractures and set treatment goals. It will also update clinicians on new and emerging therapies.
This Industry-Supported Symposium (ISS) will be held in conjunction with the ASBMR 2016 Annual Meeting and is not a part of the official program of the American Society for Bone and Mineral Research. The Potomac Center for Medical Education and Rockpointe are responsible for the organization and scientific content for this event in accordance with the Essential Areas and Policies of the ACCME as well as with FDA guidelines.
- Case Presentation – Part 1
- Strategies to improve the detection and diagnosis of osteoporosis
- Case Presentation – Part 2
- Challenges in identification of patients in need
- Case Presentation - Part 3
- New treatment options for building better bone
- Conclusion / Q&A Session
This activity is intended for ASBMR (American Society of Bone and Mineral Research) members.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
- Recognize current practice gaps that hinder the early detection and management of osteoporosis
- Identify evolving management strategies in osteoporosis and treatment goals
- Describe the place of novel and emerging therapies in the treatment of osteoporosis based on new insights from bone biology
John P. Bilezikian, MD, MACE, MACP
Dorothy L. and Daniel H. Silberberg Professor of Medicine
Vice-Chair, International Education and Research
Professor of Pharmacology
Chief Emeritus, Division of Endocrinology
College of Physicians and Surgeons
New York, NY
E. Michael Lewiecki, MD, FACP, FACE
Clinical Assistant Professor of Medicine
University of New Mexico School of Medicine
New Mexico Clinical Research & Osteoporosis Center
Paul D. Miller, MD, FACP
Colorado Center for Bone Research
Clinical Professor of Medicine
University of Colorado, Health Sciences Center
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, the post-test, or evaluation, please email email@example.com.
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
Method of Participation
To complete the activity and receive credit, the participant must attend the program and complete the evaluation form. CME certificates will be distributed onsite.
There are no fees associated with this program.
Event staff will be glad to assist you with any special needs. Please email firstname.lastname@example.org at least 5 days prior to the program.
Jointly provided by Potomac Center for Medical Education and Rockpointe
This activity is supported by an educational grant from Radius Health, Inc.